Success Metrics

Clinical Success Rate
87.4%

Based on 26,380 completed trials

Completion Rate
87%(26380/30169)
Active Trials
4,744(12%)
Results Posted
48%(12545 trials)
Terminated
3,789(9%)

Phase Distribution

Ph phase_1
8,020
20%
Ph not_applicable
6,722
16%
Ph phase_3
8,783
21%
Ph early_phase_1
564
1%
Ph phase_2
12,719
31%
Ph phase_4
4,125
10%

Phase Distribution

8584

Early Stage

12719

Mid Stage

12908

Late Stage

Phase Distribution40933 total trials
Early Phase 1First-in-human
564(1.4%)
Phase 1Safety & dosage
8,020(19.6%)
Phase 2Efficacy & side effects
12,719(31.1%)
Phase 3Large-scale testing
8,783(21.5%)
Phase 4Post-market surveillance
4,125(10.1%)
N/ANon-phased studies
6,722(16.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.7%

26380 of 31536 finished

Non-Completion Rate

16.3%

5156 ended early

Currently Active

4744

trials recruiting

Total Trials

41,034

all time

Status Distribution
Active(6157)
Completed(26380)
Terminated(5156)
Other(3341)

Detailed Status

Completed26380
Terminated3789
Recruiting3351
unknown3227
Active, not recruiting1393
Withdrawn1367

Development Timeline

Analytics

Development Status

Total Trials
41034
Active
4744
Success Rate
87.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 1564 (1.4%)
Phase 18020 (19.6%)
Phase 212719 (31.1%)
Phase 38783 (21.5%)
Phase 44125 (10.1%)
N/A6722 (16.4%)

Trials by Status

completed2638064%
active_not_recruiting13933%
unknown32278%
recruiting33518%
withdrawn13673%
enrolling_by_invitation1270%
not_yet_recruiting12863%
suspended1140%
terminated37899%

Recent Activity

Clinical Trials (41,034)

Showing 20 of 41,034 trialsScroll for more
NCT06585449Phase 1

A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease

Recruiting
NCT07503444Phase 3

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

Not Yet Recruiting
NCT07053423Phase 4

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Recruiting
NCT06159673Phase 2

ACP-204 in Adults With Alzheimer's Disease Psychosis

Recruiting
NCT04333576Phase 3

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Active Not Recruiting
NCT07295717Phase 1

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

Recruiting
NCT05167721Phase 2

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy

Active Not Recruiting
NCT00687518Not Applicable

Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers

Completed
NCT05711082Not Applicable

REALITY MONITORING AND DOPAMINE

Recruiting
NCT07224581Phase 3

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

Recruiting
NCT02264288Phase 2

Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

Terminated
NCT07646587Phase 2

A Study to Assess the Safety, Tolerability, PK and PD of WIN378 in Participants With Moderate - Severe COPD

Recruiting
NCT06845202Phase 1

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Recruiting
NCT04350138Phase 2

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

Active Not Recruiting
NCT05841095Phase 1

Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104

Active Not Recruiting
NCT06401044Phase 1

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Recruiting
NCT07133633Phase 2

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Recruiting
NCT07176390Phase 2

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Active Not Recruiting
NCT05231785Phase 1

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

Recruiting
NCT06660394Phase 3

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
41,034